Sepsis, an acute inflammation triggered by infection, is a leading cause of childhood mortality, claiming roughly 3 million children under the age of five annually. Efferon , a startup selected as one of TechCrunch Disrupt 2026’s Startup Battlefield 200 , is on a mission to drastically lower that number. The company has developed a medical device that it says lowers organ failure rates and significantly accelerates recovery in children. When standard treatments like antibiotics cannot stop the…
Why this update matters
This developing story is relevant for readers tracking technology because it reflects fresh changes from the original source and signals where attention is shifting next.
Key details
The report was collected automatically and prepared for publication with a newsroom workflow that focuses on clarity, search visibility, and quick understanding.
Readers should review the original source for direct statements, official notices, and any later corrections or additions as the story evolves.
Related coverage
Continue reading with more reporting from the same topic cluster.